Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
that this immune score may be a useful tool for overall survival prediction and treatment guidance for patients with breast cancer . breast cancer , meta-analysis, overall survival, immunotherapy Introduction Breast ...
referred to the UCSF Clinical Genetics program based on providers’ suspicion of a hereditary cancer syndrome. Patients were evaluated by a GC , and, if deemed appropriate, germline genetic testing was ordered ...
, drugs that block the action of estrogen receptor (ER)α in patients with ERα+ breast cancer or the androgen receptor (AR) in patients with prostate cancer have provided remarkable improvements in survival ...
against cancer , but only a minority of patients benefit from it. Genetic-based technologies have significantly promoted the development of cancer immunotherapy . Here we describe genetic-based cancer ...
to rely heavily on hormonal influences. These include breast , prostate , endometrial, and ovarian cancers . Breast , endometrial, and ovarian cancers are under the control of estrogen and, to a lesser degree ...
with cancer with germline BRCA1 and BRCA2 mutations [33, 34]. Patients possessing germline mutations in DNA damage repair genes have a higher risk of developing certain cancers , including prostate , breast ...
atezolizumab (89Zr-atezolizumab) in patients with metastatic bladder cancer , non-small-cell lung cancer or triple-negative breast cancer . Uptake was generally high in tumors, particularly in bladder cancer . High ...
in Urology. With PSA and anti-PSA antiserum, we were able to show circulating PSA in prostate cancer patients , a finding that was published in July 1980 (42). The first author, Larry Papsidero ...
. For example, patients with HER2-amplified breast cancer and EGFR-mutated lung cancer can be treated with specific inhibitors like trastuzumab and gefitinib or erlotinib, respectively [4–6]. Poly (ADP-ribose ...
have suggested that MSCs could promote cancer recurrence [19–41]. In fact, ASCs could active and improve the growth of resting and residual breast cancer cells after surgery in breast cancer patients ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!